The effects of tyrphostine Ag 556 on experimental spinal cord ischemia reperfusion injury

Surgical Neurology

Volumn 61, Issue 1, 2004, Pages 45-54

  Usul, Haydar ^a,b   Cakir, Ertugrul ^a   Cobanoglu, Umit ^a   Alver, Ahmet ^a   Peksoylu, Bekircan ^a   Topbas, Murat ^a   Baykal, Suleyman ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Ischemia reperfusion injury; Spinal cord; Tyrphostin Ag 556

Indexed keywords

MALONALDEHYDE; N (4 BUTYLPHENYL) ALPHA CYANOCAFFEIC ACID AMIDE; TYRPHOSTIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CELL STRUCTURE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOLOGY; NONHUMAN; RAT; REPERFUSION INJURY; SHAM FEEDING; SPINAL CORD ISCHEMIA; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE;

EID: 0347357696     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(03)00539-1     Document Type: Article

References (40)

1. Alhan E., Çiçek R., Erçin C., Örem A., Vaninor B., Cinel A. Effects of the tyrosine kinase inhibitor Tyrphostin AG-556 on acute necrotizing pancreatitis in rats. Eur J Surg. 168:2002;557-562.
2. Andreis P.G., Neri G., Tortorella C., Gottardo L., Nussdorfer G.G. Tyrphostin-23 enhances steroid-hormone secretion from dispersed human and rat adrenocrotical cells. Endocr Res. 26:2000;319-332.
3. Azbill R.D., Mu X., Bruce-Keller A.J., Mattson M.P., Springer J.E. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res. 765:1997;283-290.
4. Blight A.R. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull. 22:1989;47-52.
5. Brenner T., Poradosu E., Soffer D., Sicsic C., Gazit A., Levitzki A. suppression of experimental autoimmune encephalomyelitis by Tyrphostin AG 556. Exp Neurol. 154:1998;489-498.
6. Cambria R.P., Davison J.K., Zannetti S., et al. Clinical experience with epidural cooling for spinal cord protection during thoracic and thoracoabdominal aneurysm repair. J Vasc Surg. 25:1997;234-241.
7. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol. 151:1998;77-88.
8. Cassada D.C., Tribble C.G., Kaza A.K., et al. Adenosine analogue reduces spinal cord reperfusion injury in a time-depentent fasion. Surgery. 130:2001;230-235.
9. Coselli J.S., LeMaire S.A. Left heart bypass reduces paraplegia rates after thoracoabdominal aortic aneurysm repair. Ann Thorac Surg. 67:1999;1931-1934.
10. Cross A.H., Cannella B., Brosnam C.F., Raine C.S. Horning to CNS vasculature by antigen specific lymphocytes. Lab Invest. 63:1990;162-170.
11. Demediuk P., Saunders R.D., Anderson D.K., Means E.D., Horrocks L.A. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc Natl Acad Sci USA. 82:1985;7071-7075.
12. Faden A.I., Chan P.H., Longar S. Alterations in lipid metabolism, Na-K-ATPase activity and tissue water content of spinal cord following experimental traumatic injury. J Neurochem. 48:1987;1809-1816.
13. Gale K., Kerasidis H., Wrathall J.R. spinal cord contusions in the rat behavioral analysis of functional neurologic impairment . Exp Neurol. 88:1985;123-134.
14. Gazit A., Yaish P., Gilon C., Levitzki A. Tyrphostins I synthesis and biological activity of protein tyrosine kinase inhibitors . J Med Chem. 32:1989;2344-2352.
15. Grum D.F., Svensson L.G. Changes in cerebrospinal fluid pressure and spinal cord perfusion pressure prior to cross-clamping of the thoracic aorta in humans. J Cardiothorac Vasc Anesth. 5:1991;331-336.
16. 2 treatment. J Surg Res. 40:1986;167-179.
17. 2 administration on renal function and cellular metabolism following renal ischemia. Circulatory Shock. 16:1985;337-346.
18. 2 treatment on kidney preservation and on recovery of graft function. Res Exp Med. 178:1980;3-9.
19. Jarrar D., Wang P., Song G.Y., Cioffi W.G., Bland K.I., Chaudry I.H. Inhibition of tyrosine kinase signals after trauma-hemorrhage. Ann Surg. 23:2001;339-407.
20. Kurihara M. Role of monoamines in experimental spinal cord injury in rats. Relationship between Na-K ATPase and lipid peroxidation. J Neurosurg. 62:1985;743-749.
21. Levitzki A., Gazit A. Tyrosine kinase inhibition an approach to drug development . Science. 267:1995;1782-1788.
22. Marhaba R., Mary F., Pelassy C., Stanescu A.T., Aussel C., Breittmayer J.P. Tyrphostin A9 inhibits calcium release-dependent phosphorylations and calcium entry via calcium release-activated channel in Jurkat T cells. J Immunol. 157:1996;1468-1473.
23. Mollace V., Nottet H.S., Clayette P., et al. Oxidative stress and neuroAIDS triggers, modulators and novel antioxidants . Trends Neurosci. 24:2001;411-416.
24. Nichols M.R., Morimoto B.H. Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51. Arch Biochem Biophys. 366:1999;224-230.
25. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 264:(5163):1994;1319-1322.
26. Paidas C.N., Dudgeon D.L., Haller J.A. Jr., Clemens M.G. Adenosine triphosphate a potential therapy for hypoxic pulmonary hypertension . J Pediatr Surg. 23:1988;1154-1160.
27. Raine C.S. Biology of disease analysis of autoimmune demyelination items impact upon multiple sclerosis. Lab Invest. 50:1984;608-635.
28. Regan R.F., Choi D.W. Glutamate neurotoxicity in spinal cord cell culture. Neurosci. 43:1991;585-591.
29. Sandler A.N., Tator C.H. Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord. J Neurosurg. 45:1976;638-646.
30. Saunders R.D., Dugan L.L., Demediuk P., Means E.D., Horrocks L.A., Anderson D.K. Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem. 49:1987;24-31.
31. Schubert D., Kimura H., Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA. 89:1992;8264-8267.
32. Senter H.J., Venes J.L. Loss of autoregulation and posttraumatic ischemia following experimental spinal cord trauma. J Neurosurg. 50:1979;198-206.
33. Sevransky J.E., Shaked G., Novogrodsky A., et al. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. J Clin Invest. 99:1997;1966-1973.
34. Stokes B.T., Fox P., Hollinden G. Extracellular calcium activity in the injured spinal cord. Exp Neurol. 80:1983;561-572.
35. Vanichkin A., Patya M., Gazit A., Levitzki A., Novogrodsky A. Late administration of a lipophilic tyrosine kinase inhibitor prevents lipopolysaccharide and Escherichia coli-induced lethal toxicity. J Infect Dis. 173:1996;927-933.
36. Wolfe L.S. Eicosanoids prostaglandins, tromboxanes, leukotrienes and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem. 38:1982;1-14.
37. Yaish P., Gazit A., Gilon C., Levitzki A. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science. 242:1988;933-935.
38. Yashon D., Bingham W.G., Faddoul E.M., Hunt W.E. Edema of the spinal cord following experimental impact trauma. J Neurosurg. 38:1973;693-697.
39. Yoneda T., Lyall R.M., Alsina M.M., et al. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res. 51:1991;4430-4435.
40. Yoshida S., Busto R., Watson B.D., Santiso M., Ginsberg M.D. Postischemic cerebral lipid peroxidation in vitro modification by dietary vitamin E . J Neurochem. 44:1985;1593.